Catabasis Pharmaceuticals to Report Third Quarter 2017 Financial Results & Recent Corporate Developments on Thursday, Novembe...
November 02 2017 - 8:00AM
Business Wire
The Company will Host a Conference Call at
4:30pm ET
Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage
biopharmaceutical company, will report third quarter 2017 financial
results after the NASDAQ Global Market close on Thursday, November
9, 2017. Jill C. Milne, Ph.D., Chief Executive Officer, will host a
conference call and webcast at 4:30pm ET to provide an update on
corporate developments and to discuss third quarter financial
results.
Conference Call Dial-In Information:
Participant Toll-Free Dial-In Number:
(877) 388-2733 Participant International Dial-In Number:
(541) 797-2984 Pass Code: 99108456
Please specify to the operator that you would like to join the
“Catabasis Third Quarter 2017 Results Call.”
Interested parties may access a live audio webcast of the
conference call via the investor section of the Catabasis website,
www.catabasis.com. Please connect to the Catabasis website several
minutes prior to the start of the broadcast to ensure adequate time
for any software download that may be necessary. The webcast will
be archived for 90 days.
About CatabasisAt Catabasis Pharmaceuticals, our mission
is to bring hope and life-changing therapies to patients and their
families. Our SMART (Safely Metabolized And Rationally Targeted)
Linker drug discovery platform enables us to engineer molecules
that simultaneously modulate multiple targets in a disease. We are
applying our SMART LinkerSM platform to build an internal pipeline
of product candidates for rare diseases and plan to pursue
partnerships to develop additional product candidates. For more
information on the Company's drug discovery platform and pipeline
of drug candidates, please visit www.catabasis.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171102005132/en/
Investor and Media ContactCatabasis
Pharmaceuticals, Inc.Andrea Matthews,
617-349-1971amatthews@catabasis.com
Catabasis Pharmaceuticals (NASDAQ:CATB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Catabasis Pharmaceuticals (NASDAQ:CATB)
Historical Stock Chart
From Apr 2023 to Apr 2024